These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

740 related items for PubMed ID: 20922626

  • 61. PET in lung cancer.
    Coleman RE.
    J Nucl Med; 1999 May; 40(5):814-20. PubMed ID: 10319756
    [Abstract] [Full Text] [Related]

  • 62. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, Hussain H, Davila R, Ylagan L, Moley JF.
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [Abstract] [Full Text] [Related]

  • 63. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
    Cronin P, Dwamena BA, Kelly AM, Carlos RC.
    Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.
    Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S.
    Surgery; 2005 Dec; 138(6):1166-74; discussion 1174-5. PubMed ID: 16360405
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, Erginel S.
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [Abstract] [Full Text] [Related]

  • 69. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
    Veronesi G, Bellomi M, Scanagatta P, Preda L, Rampinelli C, Guarize J, Pelosi G, Maisonneuve P, Leo F, Solli P, Masullo M, Spaggiari L.
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):611-7. PubMed ID: 18805261
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
    Gupta NC, Maloof J, Gunel E.
    J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
    [Abstract] [Full Text] [Related]

  • 72. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.
    Evangelista L, Panunzio A, Cervino AR, Vinante L, Al-Nahhas A, Rubello D, Muzzio PC, Polverosi R.
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer.
    Allen-Auerbach M, Yeom K, Park J, Phelps M, Czernin J.
    J Nucl Med; 2006 Feb; 47(2):298-301. PubMed ID: 16455636
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. [Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer].
    Borrego-Dorado I, Vázquez-Albertino R.
    Rev Esp Med Nucl; 2009 Feb; 28(3):167-72. PubMed ID: 19558959
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.